The South African Tuberculosis Vaccine Initiative (SATVI), located within the Institute of Infectious Disease and Molecular Medicine (IIDMM), UCT, is involved in novel TB vaccine research. We are seeking to appoint a highly experienced Epidemiologist and invite applications from suitably qualified candidates for appointment to this 3-year contract position.
The main purpose of this position is to develop the organisation’s capacity to do advanced epidemiological studies. The Chief Research Officer will further be responsible for developing and sustaining a TB epidemiological research component within SATVI to complement TB vaccine development. Successful grant funding for new projects, development of a corps of epidemiology post-graduate students and post-doctoral fellows, and publication of high impact papers will be key to the success of this initiative.
The annual cost of employment, including benefits, is between R539 218 and R837 169, depending on qualifications and experience.
Please e-mail the completed UCT Application form (HR201) and all other relevant documentation as indicated on the form, with the subject line “SATVI: CRO” followed by the reference number to Melanie Falken at firstname.lastname@example.org
An application which does not comply with the above requirements will be regarded as incomplete.
Address: Staff Recruitment and Selection, University of Cape Town, Private Bag X3, Rondebosch, 7700, South Africa.
Telephone: +27 21 650 5764
Departmental website: www.satvi.uct.ac.za
Reference number for this position: SR546/13
Closing date for applications: 27 September 2013
UCT is committed to the pursuit of excellence, diversity and redress. Read our Employment Equity Policy.
Be part of our network of leaders and innovators.Join now